Cytokinetics, Inc. (CYTK)
65.42
+0.05
(+0.08%)
USD |
NASDAQ |
Apr 16, 16:00
65.55
+0.13
(+0.20%)
After-Hours: 05:36
Cytokinetics Free Cash Flow : -534.82M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Bristol Myers Squibb Co. | 12.84B |
| Regeneron Pharmaceuticals, Inc. | 3.765B |
| AtriCure, Inc. | 48.28M |
| Johnson & Johnson | 19.70B |
| Corcept Therapeutics, Inc. | 141.78M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -142.65M |
| Cash from Investing (Quarterly) | -71.19M |
| Cash from Financing (Quarterly) | 110.70M |
| Free Cash Flow Per Share (Quarterly) | -1.211 |
| Free Cash Flow to Equity (Quarterly) | -235.68M |
| Free Cash Flow to Firm (Quarterly) | -117.96M |
| Free Cash Flow Yield | -6.81% |